Harmony Biosciences director receives 17,710 stock options
Harmony Biosciences Holdings, Inc. director Troy A. Ignelzi reported receiving a stock option grant for 17,710 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Harmony Biosciences Holdings, Inc. director Troy A. Ignelzi reported receiving a stock option grant for 17,710 shares of common stock. The option has an exercise price of $27.74 per share and expires on April 2, 2036. This is a compensation-related award, not an open-market trade.
The option will vest in 36 equal monthly installments beginning on May 2, 2026, meaning the right to exercise the option will phase in gradually over three years.
Insider Trade Summary
Grant/Award: 17,710 shares
Grant/Award
1 txn
Insider
Ignelzi Troy A.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 17,710 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 17,710 contracts (Direct)
Footnotes (1)
- F1. The stock option shall vest in 36 equal monthly installments beginning on May 2, 2026.
Key Figures
Stock options granted: 17,710 options
Exercise price: $27.74 per share
Expiration date: April 2, 2036
+2 more
5 metrics
Stock options granted
17,710 options
Grant covering 17,710 underlying common shares
Exercise price
$27.74 per share
Conversion/exercise price of the stock option
Expiration date
April 2, 2036
Option term end date
Total options after grant
17,710 options
Total derivative holdings following transaction
Vesting schedule
36 monthly installments
Vests monthly starting May 2, 2026
Key Terms
Stock Option, exercise price, vesting, expiration date, +1 more
5 terms
Stock Option financial
"The stock option shall vest in 36 equal monthly installments"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price": "27.7400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shall vest in 36 equal monthly installments beginning on May 2, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date": "2036-04-02T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title": "Common Stock""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Troy A. Ignelzi report in this Harmony Biosciences (HRMY) Form 4?
Troy A. Ignelzi reported receiving a stock option grant for 17,710 shares of Harmony Biosciences common stock. The option is a compensation award, has a $27.74 exercise price, and represents an acquisition of derivative securities rather than an open-market stock purchase or sale.
What are the key terms of the HRMY stock option granted to Troy A. Ignelzi?
The grant covers 17,710 stock options with an exercise price of $27.74 per share and an expiration date of April 2, 2036. These options relate to an equal number of common shares and were awarded at no cost as part of director compensation.
How do the Harmony Biosciences (HRMY) options granted to Ignelzi vest?
The stock option vests in 36 equal monthly installments beginning on May 2, 2026. This means one thirty‑sixth of the grant becomes exercisable each month over three years, gradually increasing the portion Ignelzi can convert to common shares.
Does the Harmony Biosciences Form 4 show any stock sales or purchases by Troy A. Ignelzi?
The Form 4 shows no open-market stock purchases or sales by Troy A. Ignelzi. It reports only a grant of 17,710 stock options as a compensation-related acquisition, with zero purchase price at grant and no disposition of existing Harmony Biosciences shares.
How many Harmony Biosciences (HRMY) options does Ignelzi hold after this transaction?
After the reported transaction, Ignelzi holds 17,710 stock options directly, corresponding to 17,710 underlying Harmony Biosciences common shares. This entire amount reflects the newly granted award, as indicated by the total shares following the transaction in the filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates